Comparison of Intravenous Ampicillin–sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial

The purpose of this study was evaluating the efficacy and safety of intravenous (IV) ampicillin–sulbactam plus nebulized colistin in the treatment of Ventilator-Associated Pneumonia (VAP) caused by MDR Acinetobacter (MDRA) in ICU patients as an alternative to IV plus nebulized colistin. In this sing...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Iran J Pharm Res
Κύριοι συγγραφείς: Pourheidar, Elham, Haghighi, Mehrdad, Kouchek, Mehran, Miri, Mir Mohammad, Shojaei, Seyedpouzhia, Salarian, Sara, Hassanpour, Rezvan, Sistanizad, Mohammad
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Shaheed Beheshti University of Medical Sciences 2019
Θέματα:
Original Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7393051/
https://ncbi.nlm.nih.gov/pubmed/32802106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2019.112466.13775
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια